SBBP - Strongbridge Biopharma plc's (SBBP) CEO John Johnson on Q2 2020 Results - Earnings Call Transcript
Strongbridge Biopharma plc (SBBP)
Q2 2020 Earnings Conference Call
August 4, 2020 08:30 am ET
Company Participants
Lindsay Rocco - Elixir Health, Public Relations
John Johnson - Chief Executive Officer
Fred Cohen - Chief Medical Officer
Rob Lutz - Chief Financial Officer
Scott Wilhoit - Chief Commercial Officer
Rich Kollender - Chief Operating Officer
Conference Call Participants
Chris Howerton - Jefferies
Hartaj Singh - Oppenheimer and Company
Avatar Jones - Stifel
Jonathan Wolleben - JMP Securities
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to Strongbridge Biopharma’s Second Quarter 2020 Earnings